These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35366768)

  • 61. Noncoding RNAs and pancreatic cancer.
    Peng JF; Zhuang YY; Huang FT; Zhang SN
    World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
    Wu Q; Yang Z; Nie Y; Shi Y; Fan D
    Cancer Lett; 2014 Jun; 347(2):159-66. PubMed ID: 24657660
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
    Feng Q; Zhang H; Yao D; Chen WD; Wang YD
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
    Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Non-coding RNAs in gastric cancer.
    Wang J; Song YX; Wang ZN
    Gene; 2015 Apr; 560(1):1-8. PubMed ID: 25659765
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma.
    Mahinfar P; Baradaran B; Davoudian S; Vahidian F; Cho WC; Mansoori B
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33806782
    [TBL] [Abstract][Full Text] [Related]  

  • 67. miRNAs and lncRNAs in reproductive development.
    Li ZF; Zhang YC; Chen YQ
    Plant Sci; 2015 Sep; 238():46-52. PubMed ID: 26259173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.
    An Y; Zhang Z; Shang Y; Jiang X; Dong J; Yu P; Nie Y; Zhao Q
    Cell Death Dis; 2015 May; 6(5):e1766. PubMed ID: 25996293
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers.
    Vaghari-Tabari M; Qujeq D; Hashemzadeh MS
    Biomed Pharmacother; 2024 Oct; 179():117368. PubMed ID: 39214010
    [TBL] [Abstract][Full Text] [Related]  

  • 70. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
    Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
    Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
    Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
    Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular mechanisms of long noncoding RNAs on gastric cancer.
    Li T; Mo X; Fu L; Xiao B; Guo J
    Oncotarget; 2016 Feb; 7(8):8601-12. PubMed ID: 26788991
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.
    Ebrahimpour A; Sarfi M; Rezatabar S; Tehrani SS
    Mol Cell Biochem; 2021 Jun; 476(6):2317-2335. PubMed ID: 33582947
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comprehensive analysis of expression profiles of long non‑coding RNAs with associated ceRNA network involved in gastric cancer progression.
    Gu W; Ren JH; Zheng X; Hu XY; Hu MJ
    Mol Med Rep; 2019 Sep; 20(3):2209-2218. PubMed ID: 31322220
    [TBL] [Abstract][Full Text] [Related]  

  • 77. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
    Deng LM; Tan T; Zhang TY; Xiao XF; Gu H
    Int J Oncol; 2019 Aug; 55(2):451-461. PubMed ID: 31268161
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
    Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q
    J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long non-coding RNAs in anti-cancer drug resistance.
    Chen QN; Wei CC; Wang ZX; Sun M
    Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Noncoding RNAs in gastric cancer: Research progress and prospects.
    Zhang M; Du X
    World J Gastroenterol; 2016 Aug; 22(29):6610-8. PubMed ID: 27547004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.